A noncanonical IRAK4-IRAK1 pathway counters DNA damage–induced apoptosis independently of TLR/IL-1R signaling
Science Signaling · 19.12.2023 · 16 (816)
DOI: 10.1126/scisignal.adh3449 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, erschienen am 19.12.2023. Verfasst von Yuanyuan Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10…. Hauptthemen laut MEDLINE: Interleukin-1 Receptor-Associated Kinases, Receptors, Interleukin-1. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Interleukin-1 receptor (IL-1R)–associated kinases (IRAKs) are core effectors of Toll-like receptors (TLRs) and IL-1R in innate immunity. Here, we found that IRAK4 and IRAK1 together inhibited DNA damage–induced cell death independently of TLR or IL-1R signaling. In human cancer cells, IRAK4 was activated downstream of ATR kinase in response to double-strand breaks (DSBs) induced by ionizing radiation (IR). Activated IRAK4 then formed a complex with and activated IRAK1. The formation of this complex required the E3 ubiquitin ligase Pellino1, acting structurally but not catalytically, and the activation of IRAK1 occurred independently of extracellular signaling, intracellular TLRs, and the TLR/IL-1R signaling adaptor MyD88. Activated IRAK1 translocated to the nucleus in a Pellino2-dependent manner. In the nucleus, IRAK1 bound to the PIDD1 subunit of the proapoptotic PIDDosome and interfered with platform assembly, thus supporting cell survival. This noncanonical IRAK signaling pathway was also activated in response to other DSB-inducing agents. The loss of IRAK4, of IRAK4 kinase activity, of either Pellino protein, or of the nuclear localization sequence in IRAK1 sensitized p53-mutant zebrafish to radiation. Thus, the findings may lead to strategies for overcoming tumor resistance to conventional cancer treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- Department of Cell, Developmental and Regenerative Biology, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- Institute for Cancer Genetics, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
- Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- Division of Pediatric Oncology, Hematology and Stem Cell Transplantation, Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
ORCID-Profile: Yuanyuan Li, Richa B Shah, Brian J Lee, Andrej Gorbatenko, Zoe Stanley, Shan Zha, Samuel Sidi
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Li, Y., Shah, R. B., Sarti, S., Belcher, A. L., Lee, B. J., Gorbatenko, A., Nemati, F., Yu, H., Stanley, Z., Rahman, M., Shao, Z., Silva, J. M., Zha, S., & Sidi, S. (2023). A noncanonical IRAK4-IRAK1 pathway counters DNA damage–induced apoptosis independently of TLR/IL-1R signaling. Science Signaling, 16(816). https://doi.org/10.1126/scisignal.adh3449
Vancouver
Li Y, Shah RB, Sarti S, Belcher AL, Lee BJ, Gorbatenko A, et al. A noncanonical IRAK4-IRAK1 pathway counters DNA damage–induced apoptosis independently of TLR/IL-1R signaling. Science Signaling. 2023;16(816). doi:10.1126/scisignal.adh3449
BibTeX
@article{Li2023,
author = {Li, Yuanyuan and Shah, Richa B and Sarti, Samanta and Belcher, Alicia L and Lee, Brian J and Gorbatenko, Andrej and Nemati, Francesca and Yu, Honglin and Stanley, Zoe and Rahman, Mahbuba and Shao, Zhengping and Silva, Jose M and Zha, Shan and Sidi, Samuel},
title = {A noncanonical IRAK4-IRAK1 pathway counters DNA damage–induced apoptosis independently of TLR/IL-1R signaling},
journal = {Science Signaling},
year = {2023},
volume = {16},
number = {816},
doi = {10.1126/scisignal.adh3449}
}
EUVIMED